The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
Myocardial Extracellular Matrix: An Ever-Changing and Diverse Entity
Open accessAbstract
The cardiac extracellular matrix (ECM) is a complex architectural network consisting of structural and nonstructural proteins, creating strength and plasticity. The nonstructural compartment of the ECM houses a variety of proteins, which are vital for ECM plasticity, and can be divided into 3 major groups: glycoproteins, proteoglycans, and glycosaminoglycans. The common denominator for these groups is glycosylation, which refers to the decoration of proteins or lipids with sugars. This review will discuss the fundamental role of the matrix in cardiac development, homeostasis, and remodeling, from a glycobiology point of view. Glycoproteins (eg, thrombospondins, secreted protein acidic and rich in cysteine, tenascins), proteoglycans (eg, versican, syndecans, biglycan), and glycosaminoglycans (eg, hyaluronan, heparan sulfate) are upregulated on cardiac injury and regulate key processes in the remodeling myocardium such as inflammation, fibrosis, and angiogenesis. Albeit some parallels can be made regarding the processes these proteins are involved in, their specific functions are extremely diverse. In fact, under varying conditions, individual proteins can even have opposing functions, making spatiotemporal contribution of these proteins in the rearrangement of multifaceted ECM very hard to grasp. Alterations of protein characteristics by the addition of sugars may explain the immense, yet tightly regulated, variability of the remodeling cardiac matrix. Understanding the role of glycosylation in altering the ultimate function of glycoproteins, proteoglycans, and glycosaminoglycans in the myocardium may lead to the development of new biochemical structures or compounds with great therapeutic potential for patients with heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–242 of 242
Baldwin, H. S., Lloyd, T. R., & Solursh, M. (1994) · Circulation Research · doi:10.1161/01.res.74.2.244 · Cited by 58
Expression and Localization of Lumican in the Ischemic and Reperfused Rat Heart.
Baba, H., Ishiwata, T., Takashi, E., Xu, G. H., & Asano, G. (2001) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.65.445 · Cited by 55
Decorin-mediated Transforming Growth Factor-β Inhibition Ameliorates Adverse Cardiac Remodeling
Jahanyar, J., Joyce, D. L., Southard, R., Loebe, M. M., Noon, G. P., Koerner, M. M., Torre‐Amione, G., & Youker, K. A. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.10.005 · Cited by 55
Versican in Health and Disease
Theocharis, A. D. (2008) · Connective Tissue Research · doi:10.1080/03008200802147571 · Cited by 53
Rother, M., Krohn, S., Kania, G., Vanhoutte, D., Eisenreich, A., Wang, X., Westermann, D., Savvatis, K., Dannemann, N., Skurk, C., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.945261 · Cited by 53
Self-citationLoike, J. D., Cao, L., Budhu, S., Hoffman, S., & Silverstein, S. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7534 · Cited by 52
Law, C., Li, J., Chou, H., Chen, Y., & Chan, H. (2012) · Toxicology · doi:10.1016/j.tox.2012.11.006 · Cited by 51
Booth, A. J., Smith, K. C., Wood, S. C., Lu, G., Lipson, K. E., & Bishop, D. K. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02826.x · Cited by 49
Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling
Finsen, A. V., Woldbæk, P. R., Li, J., Wu, J., Lyberg, T., Tønnessen, T., & Christensen, G. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00144.2002 · Cited by 48
Gupta, V., Tseng, H., Lawrence, B. D., & Grande-Allen, K. J. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.10.009 · Cited by 47
Prognostic Value of Serum Tenascin-C Levels on Long-Term Outcome After Acute Myocardial Infarction
Sato, A., Hiroe, M., Akiyama, D., Hikita, H., Nozato, T., Hoshi, T., Kimura, T., Wang, Z., Sakai, S., Imanaka‐Yoshida, K., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.02.009 · Cited by 47
Echtermeyer, F. G., Harendza, T., Hubrich, S., Lorenz, A., Herzog, C., Mueller, M., Schmitz, M., Grund, A., Larmann, J., Stypmann, J., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr149 · Cited by 46
The galactosaminoglycan-containing decorin and its impact on diseases
Seidler, D. G. (2012) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2012.07.012 · Cited by 45
Cooley, M. A., Fresco, V. M., Dorlon, M. E., Twal, W. O., Lee, N. V., Barth, J. L., Kern, C. B., Iruela‐Arispe, M. L., & Argraves, W. S. (2011) · Developmental Dynamics · doi:10.1002/dvdy.23716 · Cited by 45
Sainger, R., Grau, J. B., Poggio, P., Branchetti, E., Bavaria, J. E., Gorman, J. H., Gorman, R. C., & Ferrari, G. M. (2011) · Biomarkers · doi:10.3109/1354750x.2011.642407 · Cited by 43
Syndecan-4 over-expression preserves cardiac function in a rat model of myocardial infarction
Xie, J., Wang, J., Li, R., Dai, Q., Yong, Y., Zong, B., Xu, Y., Li, E., Ferro, A., & Xu, B. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.04.014 · Cited by 42
Development of progressive aortic vasculopathy in a rat model of aging
Miller, S. J., Watson, W. C., Kerr, K. A., Labarrere, C. A., Chen, N. X., Deeg, M. A., & Unthank, J. L. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00397.2007 · Cited by 42
Overexpression of Biglycan in the Heart of Transgenic Mice: An Antibody Microarray Study
Bereczki, E., Gonda, S., Csont, T., Korpos, É., Zvara, Á., Ferdinandy, P., & Sántha, M. (2007) · Journal of Proteome Research · doi:10.1021/pr060571b · Cited by 41
Chan, C. K., Rolle, M. W., Potter‐Perigo, S., Braun, K. R., Biber, B. P. V., Laflamme, M. A., Murry, C. E., & Wight, T. N. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22744 · Cited by 40
Ahmed, M., Øie, E., Vinge, L. E., Yndestad, A., Geir Øystein Andersen, G., Andersson, Y., Attramadal, T., & Attramadal, H. (2003) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.08.017 · Cited by 40
Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: Role of nitric oxide
Csont, T., Görbe, A., Bereczki, E., Szunyog, A., Aypar, E., Tóth, M. E., Varga, Z. V., Csonka, C., Fülöp, F., Sántha, M., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.01.013 · Cited by 39
Doi, M., Kusachi, S., Murakami, T., et al. (2000) · Pathology - Research and Practice · doi:10.1016/s0344-0338(00)80018-7 · Cited by 33
Syndecan-1: A Critical Mediator in Cardiac Fibrosis
Frangogiannis, N. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.147256 · Cited by 31
Self-citationBarascuk, N., Genovese, F., Larsen, L., Byrjalsen, I., Zheng, Q., Sun, S., Hosbond, S. E., Poulsen, T. S., Diederichsen, A. C. P., Jensen, J. M., et al. (2013) · PubMed · Cited by 30
Krishnamurthy, V. K., Opoka, A. M., Kern, C. B., Guilak, F., Narmoneva, D. A., & Hinton, R. B. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.01.001 · Cited by 30
Mersmann, J., Habeck, K., Latsch, K., Zimmermann, R., Jacoby, C., Fischer, J. W., Hartmann, C. J., Schrader, J., Kirschning, C. J., & Zacharowski, K. D. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0127-y · Cited by 30
Hellman, U., Malm, L., Ma, L., Larsson, G., Mörner, S., Fu, M. L. X., Engström‐Laurent, A., & Waldenström, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014393 · Cited by 29
Hyaluronan and its receptor CD44 in the heart of newborn and adult rats
Hellström, M., Johansson, B. H., & Engström‐Laurent, A. (2006) · The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology · doi:10.1002/ar.a.20332 · Cited by 29
Maurer, P., G�hring, W., Sasaki, T., et al. (1997) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050059 · Cited by 28
Spatial and Temporal Expression of Perlecan in the Early Chick Embryo
Soulintzi, N., & Zagris, N. (2007) · Cells Tissues Organs · doi:10.1159/000107948 · Cited by 27
Akimoto, H., Ito, H., Tanaka, M., Adachi, S., Hata, M., Lin, M., Fujisaki, H., Marumo, F., & Hiroe, M. (1996) · Circulation · doi:10.1161/01.cir.93.4.810 · Cited by 27
Inflammation and Cardiac Remodeling During Viral Myocarditis
Heymans, S. R. B. (2006) · Springer eBooks · doi:10.1007/3-540-30822-9_12 · Cited by 26
Self-citationWaldenström, A. P., Fohlman, J., ILBÄCKY, N. G., Ronquist, G. K., Hällgren, R., & Gerdin, B. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00774.x · Cited by 25
Engebretsen, K. V. T., Wæhre, A., Bjørnstad, J. L., Skrbic, B., Sjaastad, I., Behmen, D., Marstein, H. S., Yndestad, A., Aukrust, P., Christensen, G., et al. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00793.2012 · Cited by 24
The Role of Biglycan in the Heart
Bereczki, E., & Sántha, M. (2008) · Connective Tissue Research · doi:10.1080/03008200802148504 · Cited by 21
Parallel up-regulation of FGF-2 and hyaluronan during development of cardiac hypertrophy in rat
Hellman, U., Hellström, M., Mörner, S., Engström‐Laurent, A., Åberg, A., Oliviéro, P., Samuel, J., & Waldenström, A. P. (2008) · Cell and Tissue Research · doi:10.1007/s00441-007-0562-8 · Cited by 21
Friebe, V. M., Mikulis, B. T., Kole, S., Ruffing, C. S., Sacks, M. S., & Vyavahare, N. R. (2011) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31889 · Cited by 20
Lei, J., Xue, S., Wu, W., Zhou, S. X., Zhang, Y. L., Yuan, G. Y., & Wang, J. F. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1012-1 · Cited by 20
Tenascin-C in human cardiac pathology
Niebrój-Dobosz, I. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.06.011 · Cited by 16
Mataveli, F. D., Han, S. W., Nader, H. B., Mendes, A., Kanishiro, R., Tucci, P. J. F., Lopes, A. C., Baptista‐Silva, J. C. C., Marolla, A. P. C., de Carvalho, L. P., et al. (2009) · Growth Factors · doi:10.1080/08977190802574765 · Cited by 15
Effects of biglycan deficiency on myocardial infarct structure and mechanics.
Campbell, P. H., Hunt, D. L., Jones, Y., Harwood, F. L., Amiel, D., Omens, J. H., & McCulloch, A. D. (2008) · PubMed · Cited by 13
Human Myocardial Protein Pattern Reveals Cardiac Diseases
Bergquist, J., Baykut, G., Bergquist, M., Witt, M., Mayer, F. J., & Baykut, D. (2012) · International Journal of Proteomics · doi:10.1155/2012/342659 · Cited by 9
Cited by
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Prabhu, S. D., & Frangogiannis, N. G. (2016) · Circulation Research · doi:10.1161/circresaha.116.303577 · Cited by 2,224
Self-citationProteoglycan form and function: A comprehensive nomenclature of proteoglycans
Iozzo, R. V., & Schaefer, L. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.003 · Cited by 1,263
The extracellular matrix in myocardial injury, repair, and remodeling
Frangogiannis, N. G. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87491 · Cited by 524
Self-citationMolecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation
Nattel, S. (2017) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2017.03.002 · Cited by 491
Angiogenesis after acute myocardial infarction
Wu, X., Reboll, M. R., Korf-Klingebiel, M., & Wollert, K. C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa287 · Cited by 379
Metadata
- Authors
- Rienks, M., Papageorgiou, A.-P., Frangogiannis, N. G., & Heymans, S.
- Venue
- Circulation Research
- Published
- 2014-02-28
- Volume
- 114
- Issue
- 5
- Pages
- 872-888
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2013840481
- Cited by
- 366
- References
- 242
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.